Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares CT (computed tomography), Etoposide, TP53, Cisplatin and the tags subtype-page, endocrine.
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Lutetium-177 dotatate, CT (computed tomography) and the tags subtype-page, endocrine.
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Lutetium-177 dotatate, Small intestinal neuroendocrine tumours and the tags subtype-page, endocrine.
Shares Etoposide, TP53, Cisplatin and the tags subtype-page, endocrine.
Shares Platinum + etoposide (EP / CE), DLL3, Tarlatamab, PET (positron emission tomography) and the tag subtype-page.
Shares Small cell neuroendocrine carcinoma of the cervix, Topotecan, Atezolizumab, Cisplatin and the tag subtype-page.
Shares PET (positron emission tomography), Etoposide, Cisplatin, Carboplatin and the tag subtype-page.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Durvalumab, Nivolumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.